Following the progress and success of the Glaucoma Specialists Advisory Panel, Endo Optiks is pleased to announce the appointment of a new Medical Advisory Board of Retina Specialists. This small but esteemed team of Retina surgeons are excited to share their enthusiasm and experience in the field of ophthalmic endoscopy in vitreo-retinal surgery. The Board is chaired by Dr. Jeffrey Heier.

Meet the Board

Thomas A. Albini, M.D.
Jeffrey S. Heier, M.D.
Allen C. Ho, M.D.
Victor H. Gonzalez, M.D.
Thomas C Lee, M.D.
Sui Chien Wong, MB BS

Thomas A. Albini, M.D.
Associate Professor of Clinical Ophthalmology
Bascom Palmer Eye Institute
Miami, Florida

Dr. Albini received a Bachelor of Arts degree, Magna Cum Laude, from Princeton University and a Doctor of Medicine degree from Johns Hopkins University School of Medicine. He completed an ophthalmology residency at Doheny Eye Institute of the University of Southern California. He then completed a uveitis clinical and research fellowship at Doheny Eye Institute and a vitreoretinal fellowship at Cullen Eye Institute of the Baylor College of Medicine. Dr. Albini currently is an Associate Professor of Clinical Ophthalmology at the Bascom Palmer Eye Institute in Miami, FL. He is a member of numerous professional and honorary societies, including the American Academy of Ophthalmology, the American Society of Retina Specialists, The Retina Society, the Macula Society, the American Uveitis Society and the International Uveitis Study Group. He is currently President of the Vit Buckle Society. He also served as Editor-in-Chief of the American Society of Retina Specialists’ web site for 4 years. Dr. Albini has received numerous awards including an Achievement Award from the American Academy of Ophthalmology and a Senior Achievement Award from the American Society of Retina Specialists. He has authored over 110 peer-reviewed articles on clinical and experimental topics in vitreoretinal disease and uveitis.

Jeffrey Heier, M.D.
Boston Eye Surgery
& Laser Center
50 Staniford St.
Boston, MA 02114
(617) 314-1803
(617) 723-7787

Jeffrey S. Heier, M.D., is a Vitreoretinal Specialist and the Director of Retina Research at Ophthalmic Consultants of Boston (OCB), one of the largest and most prestigious multi-specialty ophthalmology practices in the United States. Dr. Heier is the Co-Director of the Vitreoretinal Fellowship at OCB/Tufts Medical School in Boston, Massachusetts. Dr. Heier’s academic appointments include an instructorship in ophthalmology at Tufts University School of Medicine and Harvard University Medical School, both in Boston.

Dr. Heier received his medical degree from Boston University, then did a transitional internship and ophthalmology residency at Fitzsimons Army Medical Center. Between his internship and residency, Dr. Heier served as a physician in a Combat Support Hospital in the Persian Gulf War, where he was awarded a Bronze Star. Dr. Heier then completed a vitreoretinal fellowship at Ophthalmic Consultants of Boston/Tufts University School of Medicine.

Dr. Heier is the Secretary of Online Education for the American Academy of Ophthalmology and the past President of the Center for Eye Research and Education Foundation in Boston, MA. Dr. Heier is a member of the American Society of Retina Specialists, the Retina Society, and the Macula Society.

From the American Academy of Ophthalmology, Dr. Heier received the Senior Achievement Award in 2010, the Secretariat Award in 2007, and the Honor Award in 2003. He is also the recipient of the Honor Award and Senior Honor Award from the American Society of Retina Specialists.

Dr. Heier is one of the leading retinal clinical researchers in the country for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina. He serves on the Scientific Advisory Board or as Clinical Design Consultant to over twenty biotechnical or pharmaceutical companies.

Dr. Heier lectures nationally and internationally on retinal research and the innovative approach to the treatment of retinal diseases. He has authored or co-authored numerous works in peer-reviewed journals, as well as served as a reviewer for Ophthalmology, Archives of Ophthalmology, American Journal of Ophthalmology, Retina, and numerous other journals.

Dr. Heier enjoys time with his family, especially watching, with his wife of over 25 years, his two beautiful daughters as they dance at Boston Ballet.

Allen C. Ho, M.D.
Director,
Clinical Retina Research Unit
Wills Eye Inst. Retina Service
Professor of Ophthalmology
Jefferson University

Dr. Allen C. Ho is an internationally recognized retina specialist who specializes in state of the art and compassionate patient care and is a leader in the development of new medical and surgical treatments for retinal disease. He is a Phi Beta Kappa graduate of Cornell University College of Arts and Sciences, receiving highest distinction in all subjects. He graduated from Columbia University College of Physicians and Surgeons and was elected Co-Chief Resident during his ophthalmology residency at Wills Eye Hospital. He completed a Fellowship in Vitreoretinal Diseases at Manhattan Eye, Ear and Throat Hospital where he was awarded a Heed Ophthalmic Fellowship. Currently, he is Attending Surgeon at Wills Eye Institute and Director of Retina Research at Wills Eye Hospital. He is former Co-Director of the Wills Retina Fellowship, widely recognized as the premier retina training program in the country. He has received the American Society of Retina Specialists’ Crystal Apple Award recognizing his mentorship of retina fellowship trainees.

Dr. Ho is Board Certified in Ophthalmology, an Associate Examiner for the American Board of Ophthalmology and a Fellow of the American College of Surgeons. He is an active member and leader in several ophthalmologic societies including: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, The American Society of Retina Specialists, The Macula Society, The Retina Society, The Society of Heed Fellows, and the Pennsylvania Academy of Ophthalmology. He serves on the Executive Committee of the Retina Society.

He is Professor of Ophthalmology at Thomas Jefferson University School of Medicine. Dr. Ho is Editor-in-Chief of Current Opinion in Ophthalmology and Chief Medical Editor of Retina Today, a global publication that features new treatments for retinal disease. He is an invited lecturer at numerous national and international ophthalmic meetings. Dr. Ho has authored numerous scientific publications on retinal disease, is author of The Wills Eye Hospital Color Atlas and Synopsis of Retinal Disease and Age Related Macular Degeneration Diagnosis and Treatment, and is a member of the Editorial Review Boards of Ophthalmic Surgery Lasers and Imaging, Ophthalmology Times, Ocular Surgery News, and Evidence Based Ophthalmology. He is a recipient of multiple clinical research grants investigating new treatments for macular diseases sponsored by the National Eye Institute and received the American Academy of Ophthalmology’s Senior Achievement Award. He is an invited Advisory Board member for the Alcon Vitreoretinal Surgical Advisory Committee and the Ophthalmic Devices Committee of the United States Food and Drug Administration. He is a scientific advisor for many surgical device and pharmaceutical companies pursuing improved treatments for macular and retinal disease.

Dr. Ho is the Principal Investigator at Wills Eye Hospital of several collaborative clinical trials evaluating new treatments for age-related macular degeneration and diabetic retinopathy and maintains special interests in macular diseases, diabetic retinopathy, surgical retinal diseases and clinical trials investigating new treatments for vitreoretinal diseases. Dr. Ho was named to Castle Connolly’s “Best Doctors in America”, “America’s Top Ophthalmologists” and “Top Doctors of Philadelphia” as elected by peer physicians. He is a volunteer for Eye Care America, serving underinsured Americans with medical need and a member of the Board of the American Diabetes Association of Greater Philadelphia whose mission is to improve the care and quality of life of patients with diabetes mellitus.

Victor H. Gonzalez, M.D.
Suite 1
1309 E Ridge Rd
McAllen, TX 78503
Ph: (956) 631-8875

Dr. Victor H. Gonzalez is the founder of Valley Retina Institute, P.A., a state of the art medical and surgical vitreo-retinal practice serving the Rio Grande Valley.

Thomas C. Lee, M.D.
Children’s USC
4650 West Sunset Blvd.
Los Angeles, CA 90027
(323) 361-2299 office
(323) 361-3515 fax

Dr. Lee is a graduate of Phillips Academy and earned his bachelor degree at Johns Hopkins University. He received his MD from Cornell University where he graduated with Honors in Research and was a Howard Hughes Scholar. He completed his ophthalmology residency at Cornell and then went to Harvard Medical School as a Heed Fellow where he studied retinal stem cells and the role they play in cancer. He completed his retina fellowship at Massachusetts Eye and Ear Infirmary before returning to Cornell where he was a New York Hospital Clinical Scholar. He held the position of Assistant Director of the Robert M. Ellsworth Ocular Oncology Center at Cornell and the St Giles Endowed Chair in Pediatric Retinal Diseases until being recruited to become director of the Retina Institute at Childrens Hospital Los Angeles and Associate Professor of Ophthalmology, Doheny Eye Institute, Keck School of Medicine at the University of Southern California. Since his arrival, Dr. Lee has developed the Retina Institute into a world class center and this year was promoted to Director of the Vision Center which has eight full time faculty devoted to all aspects of pediatric eye disease.

Dr. Lee has made several advances in our understanding of pediatric retinal disease and ocular tumors. He has identified novel drugs that can induce regression of tumor cells and new blood vessels that are present in both retinoblastoma as well as retinopathy of prematurity. While at Cornell he has been awarded the Distinguished House Staff Award, the Resident Teaching Award, Franklyn Ellenbogen Prize in Hematology/Oncology, and the Dean William Mecklenburg Polk Memorial Prize. Since his arrival at Children’s Hospital Los Angeles he was awarded the Doheny Resident Teaching Award and Barbara M. Korsch Medical Education Award. He has also received the Achievement Award from the American Academy of Ophthalmology for his contributions both in advancing the field as well as teaching courses to enhance the skills of other ophthalmologists. He was recently awarded the Ellis Island Medal of Honor for his teaching efforts in developing countries.

Since his arrival at CHLA, Dr. Lee has also focused on creating innovative programs to teach eye doctors in developing countries. He has developed a novel teaching platform that allows a team of doctors in the United States to provide direct patient oversight and mentoring using an Internet based approach. From 2010-2011 he established a program in conjunction with the Armenian Eye Care Project, which deployed digital retinal cameras to the capital city of Yerevan that allowed the US based experts to supervise Armenian doctors during their weekly rounding on babies with a potentially blinding disease called Retinopathy of Prematurity. In one year, this project resulted in over 1,500 supervised screening exams of 300 babies of which 40 were treated to avoid permanent blindness. The success rate of the Armenian trainees was equivalent to that of the experience physicians in the US, and as a result, the Armenian Ministry of Health has provided a certificate of proficiency based on their participation in this US based program.

As a result on the success of the pilot program in Armenia, Dr. Lee will be deploying this teaching platform to additional countries including Mongolia and China in 2012 along with Vietnam and Indonesia. It is his goal to use these programs as a model of how to provide an open-source medical education curriculum over the Internet that can be used to teach doctors in developing countries and provide them with a level of expertise comparable to what is present in the US.

Dr. Sui Chien Wong MB BS FRCSEd(Ophth) FRCOphth PGC Consultant Vitreoretinal Surgeon in Adults and Paediatrics
Great Ormond Street Hospital for Children
Moorfields Eye Hospital
Royal Free Hospital
London, UK

Dr. Wong is a consultant ophthalmologist and vitreoretinal (VR) surgeon in London, UK, at Great Ormond Street Hospital for Children (GOSH), Moorfields Eye Hospital and the Royal Free Hospital.

He is among a handful of ophthalmologists in the world with a super-specialty practice in complex paediatric vitreoretinal surgery and retinovascular diseases, in addition to his adult VR work. He is a leading expert in endoscopic vitrectomy. In 2014, he introduced novel endoscopic vitrectomy for retinopathy of prematurity (ROP) to the UK, making GOSH only one of only two centres in the world with expertise in this treatment. GOSH is now the de facto UK national surgical centre for all patients with retinal detachment in ROP, in collaboration with Oxford University.

He has published extensively in the field of paediatric vitreoretinal surgery and has run over 20 surgical courses as lead or co-instructor both in the UK and internationally. This includes being the current course directors at the American Academy of Ophthalmology annual meeting of “Advances in Intraocular Endoscopic Surgery: Anterior and Posterior Segment Techniques” since 2012 and “Paediatric Vitreoretinal Disorders: Current & Future Management”.

Additionally, Dr. Wong is the UK Chief Investigator and Moorfields Eye Hospital Principal Investigator for the RAINBOW trial, an international randomised controlled trial of intravitreal ranibizimab versus standard-of-care retinal laser.

His mentors have described him as a gifted and outstanding surgeon whose promise was evident as a Moorfields resident, when he was the best performing trainee in a surgical motion-tracking study published in Ophthalmology.

Since early 2014, he has worked closely with the Armenian EyeCare Project to train two leading Armenian surgeons to treat babies and young children with blinding retinal disease (including ROP) at the AECP national surgical center in Yerevan, including mentoring via live telesurgery, in a partnership between GOSH and Children’s Hospital Los Angeles.

His inclusion in the 2017 Power List, a global top 50 list of rising stars published by the Ophthalmologist, recognises his contribution to the field of paediatric vitreoretinal surgery.

He has recently caught the ski bug with his two beautiful young boys.